View in EDS PDF Full Text

Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
Authors: Nations KR; Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA. kari.nations@mail.utexas.edu, Dogterom P, Bursi R, Schipper J, Greenwald S, Zraket D, Gertsik L, Johnstone J, Lee A, Pande Y, Ruigt G, Ereshefsky L
Source: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2012 Dec; Vol. 26 (12), pp. 1525-39. Date of Electronic Publication: 2012 Sep 06.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22954616
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nations+KR%22">Nations KR</searchLink>; Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA. kari.nations@mail.utexas.edu<br /><searchLink fieldCode="AU" term="%22Dogterom+P%22">Dogterom P</searchLink><br /><searchLink fieldCode="AU" term="%22Bursi+R%22">Bursi R</searchLink><br /><searchLink fieldCode="AU" term="%22Schipper+J%22">Schipper J</searchLink><br /><searchLink fieldCode="AU" term="%22Greenwald+S%22">Greenwald S</searchLink><br /><searchLink fieldCode="AU" term="%22Zraket+D%22">Zraket D</searchLink><br /><searchLink fieldCode="AU" term="%22Gertsik+L%22">Gertsik L</searchLink><br /><searchLink fieldCode="AU" term="%22Johnstone+J%22">Johnstone J</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+A%22">Lee A</searchLink><br /><searchLink fieldCode="AU" term="%22Pande+Y%22">Pande Y</searchLink><br /><searchLink fieldCode="AU" term="%22Ruigt+G%22">Ruigt G</searchLink><br /><searchLink fieldCode="AU" term="%22Ereshefsky+L%22">Ereshefsky L</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228907828%22">Journal of psychopharmacology (Oxford, England)</searchLink> [J Psychopharmacol] 2012 Dec; Vol. 26 (12), pp. 1525-39. <i>Date of Electronic Publication: </i>2012 Sep 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8907828 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1461-7285 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202698811%22">02698811 </searchLink><i>NLM ISO Abbreviation: </i>J Psychopharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22954616
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/0269881112458728
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1525
    Titles:
      – TitleFull: Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nations KR
      – PersonEntity:
          Name:
            NameFull: Dogterom P
      – PersonEntity:
          Name:
            NameFull: Bursi R
      – PersonEntity:
          Name:
            NameFull: Schipper J
      – PersonEntity:
          Name:
            NameFull: Greenwald S
      – PersonEntity:
          Name:
            NameFull: Zraket D
      – PersonEntity:
          Name:
            NameFull: Gertsik L
      – PersonEntity:
          Name:
            NameFull: Johnstone J
      – PersonEntity:
          Name:
            NameFull: Lee A
      – PersonEntity:
          Name:
            NameFull: Pande Y
      – PersonEntity:
          Name:
            NameFull: Ruigt G
      – PersonEntity:
          Name:
            NameFull: Ereshefsky L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2012 Dec
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1461-7285
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal of psychopharmacology (Oxford, England)
              Type: main
ResultId 1